Sefacor Inc. Information

Pipeline in a Molecule: A new paradigm in oncology to effectively and safely treat, perhaps cure, patients with most lethal primary solid tumors. Clinical evidence for GBM/HGG and preclinical for other resectable solid tumors. Proprietary formulated drug, with great promise for GBM ready for regulatory process, excellent clinical evidence. Exceptional promise for PDAC and other solid tumors. Partners, companies, drug developers are welcome to take this to the clinic and save countless lives of people suffering from these deadly solid tumors or brain and pancreas. VCs interested in company formation are welcome. Open to licensing or let them drive the path forward. Largely clinically de-risked with excellent safety and efficacy evidence.